{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:41:19Z","timestamp":1763037679744,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s42000-021-00325-y","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T18:23:30Z","timestamp":1634322210000},"page":"33-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The clinical spectrum of X-linked adrenoleukodystrophy: from Addison\u2019s-only in men to middle-age neurologic manifestations in women"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1513-2722","authenticated-orcid":false,"given":"L\u00facia","family":"Fadiga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8365-1380","authenticated-orcid":false,"given":"Miguel","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-8820","authenticated-orcid":false,"given":"Joana","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1750-1172-7-51","volume":"7","author":"M Engelen","year":"2012","unstructured":"Engelen M, Kemp S, de Visser M et al (2012) X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7:51. https:\/\/doi.org\/10.1186\/1750-1172-7-51","journal-title":"Orphanet J Rare Dis"},{"key":"325_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S Kemp","year":"2016","unstructured":"Kemp S, Huffnagel I, Linthorst G et al (2016) Adrenoleukodystrophy \u2013 neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol 12:606\u2013615. https:\/\/doi.org\/10.1038\/nrendo.2016.90","journal-title":"Nat Rev Endocrinol"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1212\/wnl.31.10.1241","volume":"31","author":"HW Moser","year":"1981","unstructured":"Moser HW, Moser AB, Frayer KK et al (1981) Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids. Neurology 31:1241\u20131249. https:\/\/doi.org\/10.1212\/wnl.31.10.1241","journal-title":"Neurology"},{"issue":"2","key":"325_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","volume":"14","author":"W K\u00f6hler","year":"2018","unstructured":"K\u00f6hler W, Curiel J, Vanderver A (2018) Adulthood leukodystrophies. Nat Rev Neurol 14(2):94\u2013105. https:\/\/doi.org\/10.1038\/nrneurol.2017.175","journal-title":"Nat Rev Neurol"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2147\/TACG.S49590","volume":"8","author":"C Wiesinger","year":"2015","unstructured":"Wiesinger C, Eichler FS, Berger J (2015) The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8:109\u2013121. https:\/\/doi.org\/10.2147\/TACG.S49590","journal-title":"Appl Clin Genet"},{"issue":"4","key":"325_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.101","volume":"49","author":"L Bezman","year":"2001","unstructured":"Bezman L, Moser AB, Raymond GV et al (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49(4):512\u2013517. https:\/\/doi.org\/10.1002\/ana.101","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"325_CR7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/brain\/awt361","volume":"137","author":"M Engelen","year":"2014","unstructured":"Engelen M, Barbier M, Dijkstra IM et al (2014) X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain 137(Pt 3):693\u2013706. https:\/\/doi.org\/10.1093\/brain\/awt361","journal-title":"Brain"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1750-1172-9-6","volume":"9","author":"CT Habekost","year":"2014","unstructured":"Habekost CT, Schestatsky P, Torres VF et al (2014) Neurological impairment among heterozygote women for X-linked Adrenoleukodystrophy: a case control study on a clinical, neurophysiological and biochemical characteristics. Orphanet J Rare Dis 9:6. https:\/\/doi.org\/10.1186\/1750-1172-9-6","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"325_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/s1096-7192(02)00023-9","volume":"76","author":"CP Guimar\u00e3es","year":"2002","unstructured":"Guimar\u00e3es CP, Lemos M, S\u00e1-Miranda C, Azevedo JE (2002) Molecular characterization of 21 X-ALD Portuguese families: identification of eight novel mutations in the ABCD1 gene. Mol Genet Metab 76(1):62\u201367. https:\/\/doi.org\/10.1016\/s1096-7192(02)00023-9","journal-title":"Mol Genet Metab"},{"issue":"9","key":"325_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.bbadis.2012.02.009","volume":"1822","author":"M Morita","year":"2012","unstructured":"Morita M, Imanaka T (2012) Peroxisomal ABC transporters: structure, function and role in disease. Biochim Biophys Acta 1822(9):1387\u20131396. https:\/\/doi.org\/10.1016\/j.bbadis.2012.02.009","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"325_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1001\/archneur.1974.00490350064011","volume":"30","author":"JM Powers","year":"1974","unstructured":"Powers JM, Schaumberg HH (1974) Adreno-leukodystrophy. Similar ultrastructural changes in adrenal cortical and Schwann cells. Arch Neurol 30(5):406\u2013408. https:\/\/doi.org\/10.1001\/archneur.1974.00490350064011","journal-title":"Arch Neurol"},{"issue":"1","key":"325_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1530\/eje.0.1370034","volume":"137","author":"W Brennemann","year":"1997","unstructured":"Brennemann W, K\u00f6hler W, Zierz S, Klingm\u00fcller D (1997) Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol 137(1):34\u201339. https:\/\/doi.org\/10.1530\/eje.0.1370034","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"325_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1212\/wnl.46.1.112","volume":"46","author":"BM van Geel","year":"1996","unstructured":"van Geel BM, Koelman JH, Barth PG, Ongerboer de Visser BW (1996) Peripheral nerve abnormalities in adrenomyeloneuropathy: a clinical and electrodiagnostic study. Neurology 46(1):112\u2013118. https:\/\/doi.org\/10.1212\/wnl.46.1.112","journal-title":"Neurology"},{"issue":"2","key":"325_CR14","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/brain\/awy299","volume":"142","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, van Ballegoij WJC, van Geel BM et al (2019) Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness. Brain 142(2):334\u2013343. https:\/\/doi.org\/10.1093\/brain\/awy299","journal-title":"Brain"},{"issue":"1","key":"325_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13023-019-1184-4","volume":"14","author":"NJML Buermans","year":"2019","unstructured":"Buermans NJML, van den Bosch SJG, Huffnagel IC et al (2019) Overall intact cognitive function in male X-linked adrenoleukodystrophy adults with normal MRI. Orphanet J Rare Dis 14(1):217. https:\/\/doi.org\/10.1186\/s13023-019-1184-4","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"325_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1210\/jc.2018-01307","volume":"104","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, Laheji FK, Aziz-Bose R et al (2019) The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration. J Clin Endocrinol Metab 104(1):118\u2013126. https:\/\/doi.org\/10.1210\/jc.2018-01307","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"325_CR17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jpeds.2004.10.067","volume":"146","author":"P Dubey","year":"2005","unstructured":"Dubey P, Raymond GV, Moser AB et al (2005) Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr 146(4):528\u2013532. https:\/\/doi.org\/10.1016\/j.jpeds.2004.10.067","journal-title":"J Pediatr"},{"issue":"1","key":"325_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-019-1008-6","volume":"14","author":"IC Huffnagel","year":"2019","unstructured":"Huffnagel IC, Dijkgraaf MGW, Janssens GE et al (2019) Disease progression in women with X-linked adrenoleukodystrophy is slow. Orphanet J Rare Dis 14(1):30. https:\/\/doi.org\/10.1186\/s13023-019-1008-6","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"325_CR19","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1212\/01.wnl.0000059546.15529.cb","volume":"60","author":"A Fatemi","year":"2003","unstructured":"Fatemi A, Barker PB, Ulu\u011f AM et al (2003) MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy. Neurology 60(8):1301\u20131307. https:\/\/doi.org\/10.1212\/01.wnl.0000059546.15529.cb","journal-title":"Neurology"},{"issue":"2","key":"325_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.gene.2014.04.056","volume":"544","author":"X Chen","year":"2014","unstructured":"Chen X, Chen Z, Huang D et al (2014) Adult cerebral adrenoleukodystrophy and Addison\u2019s disease in a female carrier. Gene 544(2):248\u2013251. https:\/\/doi.org\/10.1016\/j.gene.2014.04.056","journal-title":"Gene"},{"issue":"1","key":"325_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00314189","volume":"235","author":"W Schlote","year":"1987","unstructured":"Schlote W, Molzer B, Peiffer J et al (1987) Adrenoleukodystrophy in an adult female. A clinical, morphological, and neurochemical study. J Neurol 235(1):1\u20139. https:\/\/doi.org\/10.1007\/BF00314189","journal-title":"J Neurol"},{"issue":"12","key":"325_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/01.wnl.0000257129.51273.73","volume":"68","author":"HH Jung","year":"2007","unstructured":"Jung HH, Wimplinger I, Jung S et al (2007) Phenotypes of female adrenoleukodystrophy. Neurology 68(12):960\u2013961. https:\/\/doi.org\/10.1212\/01.wnl.0000257129.51273.73","journal-title":"Neurology"},{"issue":"4","key":"325_CR23","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1055\/s-0041-1730937","volume":"52","author":"SIW van de Stadt","year":"2021","unstructured":"van de Stadt SIW, Huffnagel IC, Turk BR et al (2021) Imaging in X-linked adrenoleukodystrophy. Neuropediatrics 52(4):252\u2013260. https:\/\/doi.org\/10.1055\/s-0041-1730937","journal-title":"Neuropediatrics"},{"issue":"Pt 8","key":"325_CR24","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/brain\/awt143","volume":"136","author":"L Morat\u00f3","year":"2013","unstructured":"Morat\u00f3 L, Galino J, Ruiz M et al (2013) Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain 136(Pt 8):2432\u20132443. https:\/\/doi.org\/10.1093\/brain\/awt143","journal-title":"Brain"},{"issue":"4","key":"325_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s13311-019-00735-2","volume":"16","author":"C Casasnovas","year":"2019","unstructured":"Casasnovas C, Ruiz M, Schl\u00fcter A et al (2019) Biomarker identification, safety, and efficacy of high-dose antioxidants for adrenomyeloneuropathy: a phase ii pilot study. Neurotherapeutics 16(4):1167\u20131182. https:\/\/doi.org\/10.1007\/s13311-019-00735-2","journal-title":"Neurotherapeutics"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"eabc0555","DOI":"10.1126\/scitranslmed.abc0555","volume":"13","author":"L Rodr\u00edguez-Pascau","year":"2021","unstructured":"Rodr\u00edguez-Pascau L, Vilalta A, Cerrada M et al (2021) The brain penetrant PPAR\u03b3 agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy. Sci Transl Med 13:eabc0555. https:\/\/doi.org\/10.1126\/scitranslmed.abc0555","journal-title":"Sci Transl Med"},{"key":"325_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30014","author":"AB Moser","year":"2021","unstructured":"Moser AB, Liu Y, Shi X et al (2021) Drug discovery for X-linked adrenoleukodystrophy: an unbiased screen for compounds that lower very long-chain fatty acids. J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.30014","journal-title":"J Cell Biochem"},{"issue":"4","key":"325_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awx016","volume":"140","author":"JS K\u00fchl","year":"2017","unstructured":"K\u00fchl JS, Suarez F, Gillett GT et al (2017) Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy. Brain 140(4):953\u2013966. https:\/\/doi.org\/10.1093\/brain\/awx016","journal-title":"Brain"},{"issue":"7","key":"325_CR29","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","volume":"118","author":"WP Miller","year":"2011","unstructured":"Miller WP, Rothman SM, Nascene D et al (2011) Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 118(7):1971\u20131978. https:\/\/doi.org\/10.1182\/blood-2011-01-329235","journal-title":"Blood"},{"issue":"10","key":"325_CR30","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1089\/hum.2019.190","volume":"30","author":"V Poletti","year":"2019","unstructured":"Poletti V, Biffi A (2019) Gene-based approaches to inherited neurometabolic diseases. Hum Gene Ther 30(10):1222\u20131235. https:\/\/doi.org\/10.1089\/hum.2019.190","journal-title":"Hum Gene Ther"},{"issue":"17","key":"325_CR31","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","volume":"377","author":"F Eichler","year":"2017","unstructured":"Eichler F, Duncan C, Musolino PL et al (2017) Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy. N Engl J Med 377(17):1630\u20131638. https:\/\/doi.org\/10.1056\/NEJMoa1700554","journal-title":"N Engl J Med"},{"issue":"3","key":"325_CR32","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/jimd.12356","volume":"44","author":"EJ Mallack","year":"2021","unstructured":"Mallack EJ, Turk BR, Yan H et al (2021) MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: meta-analysis and consensus guidelines. J Inherit Metab Dis 44(3):728\u2013739. https:\/\/doi.org\/10.1002\/jimd.12356","journal-title":"J Inherit Metab Dis"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00325-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T14:09:12Z","timestamp":1644242952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00325-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00325-y","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local institute\u2019s committee approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent for publication was obtained from the closest relative of patient 1 and from patient 2.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}